All In MedTech

Device Trial Radar · NCT05710718

PureWick™ France and U.S. At-Home Pilot Study

A Comparative Crossover Study on the Safety, Efficacy, and Patient Quality of Life Comparing PureWick™ System With an Established Comparator in the Home Setting for Incontinence Overnight

Last checked: Nov 20, 2026Latest source record: Jul 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

17

Actual

Start

Oct 31, 2023

Primary completion

Aug 25, 2024

Study completion Aug 25, 2024

Sponsor

Lead sponsor
C. R. BardPublic (BDX)
Sponsor type
Industry
Collaborators
Becton, Dickinson and Company
First posted
Feb 2, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this prospective, post-market, multi-site, open-label, crossover trial, women with urinary incontinence requiring the use of diapers (changes complets (French term)) at night will be 1:1 randomized to a treatment sequence using two devices (PureWick™ System and Hollister® Female Urinary Pouch External Collection Device) and followed for approximately 10 weeks through 2 treatment phases. The primary objectives are to evaluate safety (skin injury) and efficacy (capture rate). Safety will be assessed using the Draize Scale and efficacy will be measured based on daily urine capture rate.

Conditions

  • Nocturnal Enuresis

Interventions

  • PureWick™ SystemDevice

    The PureWick™ FEC is intended for non-invasive urine output management in female patients. The PureWick™ FEC is a flexible, contoured external catheter that is positioned against the area where urine exits the female body. The PureWick™ FEC is connected to the PureWick™ Urine Collection System (PUCS) via connector tubing. The PUCS uses suction (not felt by the user) to pull voided urine through the device, regardless of the urine flow rate. Urine continues through vinyl tubing until it reaches a collection canister, away from the body.

  • Hollister® Female Urinary Pouch External Collection DeviceDevice

    The Hollister Female Urinary Pouch External Collection Device is intended to collect and contain urine for individuals with urinary incontinence. It is designed to be emptied and should be attached to a drainage bag. The FUP is made with hydrocolloid skin adhesive and polymer/copolymer plastics.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Daily Average Urine Capture Rate (Percentage)Time frame: Daily for 28 days during each treatment phase
  2. Daily Average Skin Irritation Score Using the Draize ScaleTime frame: Daily for 28 days during each treatment phase

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Smiths Medical Center

    Dunwoody, Georgia

  • Weill Cornell Medical Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.